GlassScriptPhysician profile
Larra S Thomas
NPI 1801349469
$2,035.91
in general payments reported to CMS, 2019-2025
16 companies · $280 in 2025
The $280 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $403 · 2022: $449 · 2023: $307 · 2024: $597 · 2025: $280.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,184.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $456.09 | 2021-2025 | Keytruda, Lynparza |
| Glaxosmithkline, LLC. | $326.39 | 2021-2024 | Jemperli, Zejula |
| Abbvie INC. | $313.62 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $235.23 | 2021-2023 | |
| Eisai INC. | $175.11 | 2021-2024 | |
| Myriad Genetic Laboratories, INC. | $169.42 | 2021-2023 | Mychoice Cdx |
| Clovis Oncology, INC. | $96.73 | 2021-2022 | |
| Seagen INC. | $93.46 | 2021-2023 | Tivdak |
| Axonics, INC. | $32.44 | 2022 | |
| Tempus Ai, INC | $29.35 | 2024 | Xt Cdx |
| Baxter Healthcare | $25.48 | 2024 | Perclot |
| Pfizer INC. | $22.41 | 2024 | |
| Caris Mpi, INC. | $20.57 | 2025 | Mi Cancer Seek |
| Foundation Medicine, INC. | $17.21 | 2022 | |
| Cashflow Solutions, LLC | $14.30 | 2025 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rigel Pharmaceuticals, INC. | $8.10 | 2023 | Rezlidhia, Tavalisse |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larra Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.